Evaluation of a commercial PET tomograph-based system for the quantitative assessment of rCBF, rOEF and rCMRO2 by using sequential administration of 15O-labeled compounds.

Source:http://linkedlifedata.com/resource/pubmed/id/12230091

Download in:

View as

General Info

PMID
12230091